显著的CD8+ T细胞动态与对新辅助癌症免疫疗法的反应有关
Housaiyin Li1, Dan P Zandberg2, Aditi Kulkarni3
1UPMC Hillman Cancer Center, Pittsburgh, PA, USA; Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA; Molecular Genetics and Development Biology Graduate Program, University of Pittsburgh, Pittsburgh, PA, USA.
Cancer cell
|March 14, 2025
概括
针对头癌的PD-1与LAG-3或CTLA-4的双重免疫疗法显示出不同的免疫细胞动态. 反PD-1+LAG-3重新编程耗尽的T细胞,而反PD-1+CTLA-4扩展现有的T细胞.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 翻译研究是翻译研究.
背景情况:
- 新辅助免疫疗法,包括免疫检查点抑制剂 (ICI),改善了头部和部状细胞癌的治疗结果.
- 与单一治疗相比,组合疗法 (抗PD-1+CTLA-4,抗PD-1+LAG-3) 显示出更高的病理反应率.
- 了解有效的ICI组合的独特作用机制对于优化治疗策略至关重要.
研究的目的:
- 在不同的新辅助ICI疗法下阐明CD8+瘤透淋巴细胞 (TILs) 独特的转录和蛋白质动态.
- 为了比较抗PD-1+LAG-3疗法和抗PD-1+CTLA-4疗法诱导的CD8+TILs的克隆和功能重编程.
- 研究T细胞受体 (TCR) 谱系变化与治疗反应之间的关系.
主要方法:
- 从临床试验中患者的CD8+TIL转录和蛋白质组资料的纵向分析 (NCT04080804).
- 对TILs的克隆性表征,以评估T细胞受体 (TCR) 的动态和多样性.
- 通过抗PD-1+LAG-3和抗PD-1+CTLA-4组合疗法诱导的细胞重编程和激活状态的比较.
主要成果:
- 抗PD-1+LAG-3疗法重新编程CD8+TILs,将其转移到I型干扰素反应,并从疲状态恢复效应器记忆 (TEM/TRM) 表型.
- 抗PD-1+CTLA-4疗法主要激活和扩展先前存在的TEM/TRM CD8+ TIL,而不会使耗尽的T细胞复原.
- 反PD-1+LAG-3显著增加了CD8+TIL群体内的TCR多样性和广泛的TCR共享,与反PD-1+CTLA-4不同.
结论:
- 新辅助抗PD-1+LAG-3和抗PD-1+CTLA-4组合免疫疗法在头癌中引起了不同的CD8+T细胞反应.
- 瘤反应性CD8+T细胞的差异性重编程和克隆动力学可能解释了这些双重治疗方案的不同疗效.
- 这些发现凸显了治疗方案特异性免疫动态在预测治疗成功方面的重要性.
相关概念视频
T Cell Activation and Clonal Selection
620
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
620
Cytotoxic T Cells-mediated Immune Response
823
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
823
T Cell Types and Functions
740
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
740
Special Features of Adaptive Immunity
703
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
703
Cell-mediated Immune Responses
66.6K
Overview
66.6K
Antigens Involved in Adaptive Immunity
431
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
431


